Loading clinical trials...
Loading clinical trials...
To study the in vivo expression of dopamine D2 receptors in prolactinoma and the predictive role of dopamine D2 receptors PET-MR imaging in the therapeutic effect of dopamine agonists.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zhebao Wu
Collaborators
NCT00001595 · Panhypopituitarism, Gigantism/Acromegaly, and more
NCT07463235 · Prolactinoma, Prolactin Excess
NCT07268183 · Prolactinoma, Macroprolactinoma
NCT07045935 · Prolactinoma
NCT00939523 · Pituitary Adenomas, Prolactinomas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions